| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 5 |
| 1 | CYCLOPHOSPHAMIDE | 4 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 4 | PREDNISONE | 4 |
| 5 | AVAPRITINIB | 3 |
| 6 | DOXORUBICIN | 2 |
| 7 | RYDAPT | 2 |
| 8 | DOXORUBICIN HYDROCHLORIDE | 1 |
| 9 | FAMOTIDINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RYDAPT | 2 | 0.0010 |
| 1 | NILOTINIB | 1 | 0.0000 |
| 2 | DOXORUBICIN HYDROCHLORIDE | 1 | 0.0000 |
| 3 | RITUXIMAB | 5 | 0.0000 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 | 0.0000 |
| 5 | CYCLOPHOSPHAMIDE | 4 | 0.0000 |
| 6 | DOXORUBICIN | 2 | 0.0000 |
| 7 | OMALIZUMAB | 1 | 0.0000 |
| 8 | FAMOTIDINE | 1 | 0.0000 |
| 9 | PREDNISONE | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 5 |
| 1 | Alkylating Drug [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 4 |
| 3 | Kinase Inhibitor [EPC] | 2 |
| 4 | Anti-IgE [EPC] | 1 |
| 5 | Histamine-2 Receptor Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 2 | Anti-IgE [EPC] | 1 | 0.0000 |
| 3 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Corticosteroid [EPC] | 4 | 0.0000 |